GALLI, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 2.955
EU - Europa 1.658
AS - Asia 1.152
SA - Sud America 106
OC - Oceania 26
AF - Africa 24
Totale 5.921
Nazione #
US - Stati Uniti d'America 2.935
RU - Federazione Russa 566
SG - Singapore 324
CN - Cina 277
IT - Italia 254
HK - Hong Kong 208
SE - Svezia 168
PL - Polonia 138
UA - Ucraina 127
IE - Irlanda 121
VN - Vietnam 117
KR - Corea 93
DE - Germania 90
BR - Brasile 82
FI - Finlandia 65
FR - Francia 63
IN - India 42
GB - Regno Unito 40
JO - Giordania 37
AU - Australia 25
CA - Canada 10
TR - Turchia 9
SC - Seychelles 8
CI - Costa d'Avorio 7
JP - Giappone 7
BD - Bangladesh 6
CO - Colombia 5
IQ - Iraq 5
MX - Messico 5
NL - Olanda 5
AZ - Azerbaigian 4
EC - Ecuador 4
ID - Indonesia 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
BE - Belgio 3
CL - Cile 3
EE - Estonia 3
SA - Arabia Saudita 3
VE - Venezuela 3
AM - Armenia 2
AT - Austria 2
BG - Bulgaria 2
EG - Egitto 2
ES - Italia 2
JM - Giamaica 2
LB - Libano 2
NG - Nigeria 2
PE - Perù 2
PK - Pakistan 2
PT - Portogallo 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PY - Paraguay 1
TT - Trinidad e Tobago 1
Totale 5.921
Città #
Santa Clara 698
Ashburn 312
Singapore 227
Fairfield 203
Jacksonville 194
Hong Kong 179
Chandler 174
Warsaw 137
Dublin 121
Cambridge 109
Seattle 99
Seoul 93
San Jose 92
Woodbridge 84
Wilmington 82
Hefei 79
Houston 72
Milan 58
The Dalles 55
Beijing 54
Buffalo 49
Ann Arbor 40
Los Angeles 38
Ho Chi Minh City 36
Altamura 34
Boardman 34
Princeton 34
Lauterbourg 29
Boston 28
Hanoi 25
Melbourne 25
Lawrence 24
Mumbai 21
Paris 20
Kent 19
Shanghai 18
San Diego 17
Rome 16
Turku 16
Helsinki 15
Moscow 15
Dong Ket 14
Munich 14
Washington 14
Medford 13
São Paulo 12
Dallas 11
Florence 11
New York 11
Turin 11
Council Bluffs 9
West Jordan 8
Abidjan 7
Auburn Hills 7
Frankfurt am Main 7
Salerno 7
Tokyo 7
Chennai 6
Hillsboro 6
Izmir 6
Orem 6
Andover 5
Frankfurt Am Main 5
Norwalk 5
Baku 4
Chicago 4
London 4
Miano 4
Montreal 4
Naples 4
Palermo 4
Philadelphia 4
Secaucus 4
St Louis 4
Brussels 3
Can Tho 3
Da Nang 3
Figino 3
Guangzhou 3
Haiphong 3
Mexico City 3
Puducherry 3
Redondo Beach 3
Stockholm 3
Tallinn 3
Verona 3
Amman 2
Baghdad 2
Barcelona 2
Bari 2
Bengaluru 2
Biên Hòa 2
Bogotá 2
Bologna 2
Bắc Ninh 2
Dhaka 2
Grand Rapids 2
Guayaquil 2
Jakarta 2
Khobar 2
Totale 3.981
Nome #
Antinociceptive profile of SM21: a novel analgesic with a presynaptic cholinergic mechanism of action 336
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazolines as glycine/N-methyl-D-aspartic acid receptor antagonists 253
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 218
ANTINOCICEPTIVE ACTIVITY OF A 3(2H)-PYRIDAZINONE DERIVATE IN MICE 209
1-Substituted pyrazolo[1,5-c]quinazolines as novel Gly/NMDA receptor antagonists: synthesis, biological evaluation and molecular modeling study 205
Structural Investigation of the 7-Chloro-3-hydroxy-1H-quinazoline-2,4-dione Scaffold to Obtain AMPA and Kainate Receptor Selective Antagonists. Synthesis, Pharmacological and Molecular Modeling Studies 198
Synthesis and biological evaluation of a new set of pyrazolo[1,5-c]quinazoline-2-carboxylates as novel excitatory amino acid antagonists 190
Synthesis and binding activity of some pyrazolo[1,5-c]quinazolines as tools to verify an optional binding site of a benzodiazepine receptor ligand. 188
ANTINOCICEPTION INDUCED BY SYSTEMIC ADMINISTRATION OF LOCAL ANAESTHETICS DEPENDS ON A CENTRAL CHOLINERGIC MECHANISM 185
Synthesis and biological evaluation of analogues of 7-chloro-4,5-dihydro-4-oxo-8-(1,2,4-triazol-4-yl)-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylic acid (TQX-173) as novel selective AMPA receptor antagonists 185
4,5-Dihydro-1,2,4-triazolo[1,5-a]quinoxalin-4-ones. Excitatory amino acid antagonists with combined glycine/NMDA and AMPA receptor affinity 181
SYNTHESIS AND BINDING STUDY OF PYRAZOLO[4,5-C][1,8]NAPHTHYRIDINES. 180
SYNTHESIS AND BIOLOGICAL ACTIVITY OF A SERIES OF ARYL TROPANYL ESTERS AND AMIDES CHEMICALLY RELATED TO 1H-INDOLE-3-CARBOXYLIC ACID ENDO 8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL ESTER 178
“3-Hydroxy-quinazoline-2,4-dione as a useful scaffold to obtain selective Gly/NMDA and AMPA receptor antagonists” 177
Structure-activity relationship studies of novel pyrazolo[1,5-c][1,3]benzoxazines: synthesis and benzodiazepine receptor affinity. 175
Benzodiazepine binding activity of some tricyclic heteroarometic systems to define the hydrogen bonding strength of the proton donors of the receptor site. 174
7-Chloro-4,5-dihydro-8-(1,2,4-triazol-4-yl)-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates as novel highly selective AMPA receptor antagonists. 174
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: synthesis and structure-activity relationships 174
SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF 1-AMINOPHTHALAZINIUM SALTS AS GABAA RECEPTOR ANTAGONISTS. 167
Presynaptic kynurenate-sensitive receptors inhibit glutamate release. 164
Synthesis, glycine/NMDA and AMPA binding activity of some new 2,5,6-trioxopyrazino[1,2,3-de]quinoxalines and of their restricted analogs 2,5-dioxo- and 4,5-dioxoimidazo[1,5,4-de]quinoxalines. 150
Synthesis and Pharmacological Studies at the Gly/NMDA, AMPA and Kainate Receptors of New Oxazolo[4,5-c]quinolin-4-one derivatives bearing different substituents at position-2 and on the fused benzo ring 149
RuvBL1 ATPase activity is essential for mitochondrial integrity and function in HCC cells 148
Pharmacokinetics of melphalan (L-PAM) during hyperthermic perfusion in patients with melanoma of the limbs 148
Tandem 3D-QSARs Approach as a Valuable Tool To Predict Binding Affinity Data: Design of New Gly/NMDA Receptor Antagonists as a Key Study. 147
Tricyclic heteroaromatic systems. 1,2,4-triazolo[4,3-a]quinoxalines and 1,2,4-triazino[4,3-a]quinoxalines: synthesis and central benzodiazepine receptor activity. 143
Tricyclic heteroaromatic systems. Pyrazolo[3,4-c]quinolin-4-ones and pyrazolo[3,4-c]quinoline-1,4-diones: synthesis and benzodiazepine receptor activity. 136
Synthesis, Ionotropic glutamate receptor binding affinity and structure-activity relationships of a new set of 4,5-dihydro-8-heteroaryl-4-oxo-1,2,4-triazolo[1,5-a]quinoxaline-2-carboxylates analogue of TQX-173 136
Synthesis and biological evaluation of a series of quinazoline-2-carboxylic acids and quinazolin-2,4-diones as glycine-NMDA antagonists: a pharmacophore model based approach. 128
Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidation. 116
Pharmacokinetics of melphalan n (L-PAM) in true and mild hyperthermic perfusion in patients with melanoma of the lower limb. A preliminary report 115
Tricyclic Heteroaromatic systems. 3-Substituted 1,2,3,5,6,7-hexahydro-2,5,6-trioxopyrazino[1,2,3-de]quinoxalines as novel antagonists at the glycine-NMDA site. 110
Synthesis of 2-substituted-3,4-dihydro-3-oxo-6,8-dichloro-2H-1,4-benzothiazin-1,1-dioxides and 1-oxides as glycine-NMDA receptor antagonists. 109
Synthesis and structure-activity relationships of 1-aminophthalazinium bromides as GABAA receptor ligands. 102
Synthesis of a set of ethyl 1-carbamoyl-3-oxoquinoxaline-2-carboxylates and their constrained analogue imidazo[1,5-a]quinoxalines-1,3,4-triones as selective Glycine/NMDA receptor antagonists. 102
The guinea pig myenteric plexus as a tool to characterize drugs active at the glycine recognition site of the NMDA receptors. 90
Totale 5.940
Categoria #
all - tutte 15.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 0 0 0 0 0 48
2021/2022218 6 24 9 11 8 7 8 16 10 5 66 48
2022/2023677 57 116 27 49 69 111 78 33 111 3 19 4
2023/2024267 9 32 48 17 19 56 10 43 3 8 13 9
2024/20251.739 52 164 90 221 549 274 13 143 54 54 71 54
2025/20261.588 232 255 144 61 206 63 188 61 84 84 36 174
Totale 5.940